AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2026
Feb 24, 2026
32853_dirs_2026-02-24_3df7a6eb-3543-4336-b410-3b15061b45ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2026-02-23
Reporting Person: Kim Hanjoon Alex (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | Common Stock | F | 12740 | $1.150 | Disposed | 2407346 | Direct |
Footnotes
F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on May 20, 2024 and March 21, 2025, which grants were originally reported on Form 4s filed with the U.S. Securities and Exchange Commission on May 21, 2024 and March 24, 2025, respectively.
F2: Includes 5,000 shares of common stock acquired by the reporting person on November 28, 2025 under the Issuer's Employee Stock Purchase Plan.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30
Regulatory Filings
2026
Jan 8